Skip to main content

Table 11 Compliance of the participants

From: The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design

Group

\( \overline{x}\pm S \)

Z

P

The treatment group

92.94 ± 7.28

−0.771

0.441

The control group

92.27 ± 8.29

  
Back to article page

Trials

ISSN: 1745-6215